A derivative of the plasma protease inhibitor α2- macroglobulin regulates the response to peripheral nerve injury

Journal of Neurochemistry

Volumn 103, Issue 2, 2007, Pages 694-705

  Arandjelovic, Sanja ^a   Dragojlovic, Nikola ^a   Li, Xiaoqing ^b   Myers, Robert R ^a,b   Campana, W Marie ^b   Gonias, Steven L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

Author keywords

2 macroglobulin; Cytokine; Low density lipoprotein receptor related protein 1; Peripheral nerve injury; Tumor necrosis factor

Indexed keywords

ALPHA 2 MACROGLOBULIN; CYTOKINE; ENDOTOXIN; INTERLEUKIN 18; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; CRUSH TRAUMA; DISEASE MODEL; HUMAN; INFLAMMATION; MACROPHAGE; MOUSE; NERVE FIBER; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RAT; SCHWANN CELL; SCIATIC NERVE;

ALPHA-MACROGLOBULINS; ANIMALS; AXONS; CELL DEATH; CELLS, CULTURED; CONSTRICTION, PATHOLOGIC; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NERVE CRUSH; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIPHERAL NERVES; PHOSPHORYLATION; PROTEASE INHIBITORS; RATS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHWANN CELLS; SCIATIC NERVE; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 34848914884     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04800.x     Document Type: Article

References (90)

1. Arandjelovic S., Hall B. D. Gonias S. L. (2005) Mutation of lysine 1370 in full-length human alpha2-macroglobulin blocks binding to the low density lipoprotein receptor-related protein-1. Arch. Biochem. Biophys. 438, 29 35.
2. Arandjelovic S., Van Sant C. L. Gonias S. L. (2006) Limited mutations in full-length tetrameric human alpha2-macroglobulin abrogate binding of platelet-derived growth factor-BB and transforming growth factor-beta1. J. Biol. Chem. 281, 17061 17068.
3. Armstrong P. B. Quigley J. P. (1999) Alpha2-macroglobulin: an evolutionarily conserved arm of the innate immune system. Dev. Comp. Immunol. 23, 375 390.
4. Bacskai B. J., Xia M. Q., Strickland D. K., Rebeck G. W. Hyman B. T. (2000) The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors. Proc. Natl Acad. Sci. USA 97, 11551 11556.
5. Barrett A. J., Brown M. A. Sayers C. A. (1979) The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule. Biochem. J. 181, 401 418.
6. Bjork I. Fish W. W. (1982) Evidence for similar conrofmational changes in alpha-2-macroglobulin on reaction with methylamine and proteolytic enzymes. Biochem. J. 207, 347 356.
7. Bosse F., Kury P. Muller H. W. (2001) Gene expression profiling and molecular aspects in peripheral nerve regeneration. Restor Neurol Neurosci 19, 5 18.
8. Boucher P. Gotthardt M. (2004) LRP and PDGF signaling: a pathway to atherosclerosis. Trends Cardiovasc. Med. 14, 55 60.
9. Boucher P., Gotthardt M., Li W. P., Anderson R. G. Herz J. (2003) LRP: role in vascular wall integrity and protection from atherosclerosis. Science 300, 329 332.
10. Campana W. M. Myers R. R. (2001) Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. FASEB J. 15, 1804 1806.
11. Campana W. M., Hiraiwa M. O'Brien J. S. (1998) Prosaptide activates the MAPK pathway by a G-protein-dependent mechanism essential for enhanced sulfatide synthesis by Schwann cells. FASEB J. 12, 307 314.
12. Campana W. M., Li X., Dragojlovic N., Janes J., Gaultier A. Gonias S. L. (2006) The low-density lipoprotein receptor-related protein is a pro-survival receptor in Schwann cells: possible implications in peripheral nerve injury. J. Neurosci. 26, 11197 11207.
13. Crookston K. P., Webb D. J., Wolf B. B. Gonias S. L. (1994) Classification of alpha 2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions. J. Biol. Chem. 269, 1533 1540.
14. Deyo R. A. Tsui-Wu Y. J. (1987a) Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine 12, 264 268.
15. Deyo R. A. Tsui-Wu Y. J. (1987b) Functional disability due to back pain. A population-based study indicating the importance of socioeconomic factors. Arthritis Rheum. 30, 1247 1253.
16. Frymoyer J. W. Cats-Baril W. L. (1991) An overview of the incidences and costs of low back pain. Orthop. Clin. North Am. 22, 263 271.
17. George A., Buehl A. Sommer C. (2004) Wallerian degeneration after crush injury of rat sciatic nerve increases endo- and epineurial tumor necrosis factor-alpha protein. Neurosci. Lett. 372, 215 219.
18. Gettins P., Crews B. C. Cunningham L. W. (1989) Preparation and initial characterization of an intermediate, half-cleaved form of human alpha 2-macroglobulin. Biochemistry 28, 5613 5618.
19. Gettins P., Beechem J. M., Crews B. C. Cunningham L. W. (1990) Separation and localization of the four cysteine-949 residues in human alpha2-macroglobulin using fluorescence energy transfer. Biochemistry 29, 7747 7753.
20. Gonias S. L. Pizzo S. V. (1981) Altered clearance of human alpha 2-macroglobulin complexes following reaction with cis- dichlorodiamineplatinum(II). Biochim. Biophys. Acta 678, 268 274.
21. Gonias S. L. Pizzo S. V. (1983) Characterization of functional human alpha 2-macroglobulin half-molecules isolated by limited reduction with dithiothreitol. Biochemistry 22, 536 546.
22. Gonias S. L., Reynolds J. A. Pizzo S. V. (1982) Physical properties of human alpha 2-macroglobulin following reaction with methylamine and trypsin. Biochim. Biophys. Acta 705, 306 314.
23. Gonias S. L., Balber A. E., Hubbard W. J. Pizzo S. V. (1983) Ligand binding, conformational change and plasma elimination of human, mouse and rat alpha-macroglobulin proteinase inhibitors. Biochem. J. 209, 99 105.
24. Gonias S. L., LaMarre J., Crookston K. P., Webb D. J., Wolf B. B., Lopes M. B., Moses H. L. Hayes M. A. (1994) Alpha 2-macroglobulin and the alpha 2-macroglobulin receptor/LRP. A growth regulatory axis. Ann. NY Acad. Sci. 737, 273 290.
25. Hall P. K. Roberts R. C. (1978) Physical and chemical properties of human plasma alpha2-macroglobulin. Biochem. J. 173, 27 38.
26. Hartung H. P., Jung S., Stoll G., Zielasek J., Schmidt B., Archelos J. J. Toyka K. V. (1992) Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40, 197 210.
27. Heumann D. Glauser M. P. (1996) Anticytokine strategies for the treatment of septic shock: relevance of animal models. Curr. Top. Microbiol. Immunol. 216, 299 311.
28. Hiraiwa M., Taylor E. M., Campana W. M., Darin S. J. O'Brien J. S. (1997) Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides. Proc. Natl Acad. Sci. USA 94, 4778 4781.
29. Hu K., Yang J., Tanaka S., Gonias S. L., Mars W. M. Liu Y. (2006) Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J. Biol. Chem. 281, 2120 2127.
30. Ide C. (1996) Peripheral nerve regeneration. Neurosci. Res. 25, 101 121.
31. Igarashi T., Kikuchi S., Shubayev V. Myers R. R. (2000) 2000 Volvo Award winner in basic science studies: exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine 25, 2975 2980.
32. Imber M. J. Pizzo S. V. (1981) Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin. J. Biol. Chem. 256, 8134 8139.
33. Janssen B. J., Huizinga E. G., Raaijmakers H. C., Roos A., Daha M. R., Nilsson-Ekdahl K., Nilsson B. Gros P. (2005) Structures of complement component C3 provide insights into the function and evolution of immunity. Nature 437, 505 511.
34. Kleinschnitz C., Brinkhoff J., Zelenka M., Sommer C. Stoll G. (2004) The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling. J. Neuroimmunol. 149, 77 83.
35. Kleinschnitz C., Brinkhoff J., Sommer C. Stoll G. (2005) Contralateral cytokine gene induction after peripheral nerve lesions: dependence on the mode of injury and NMDA receptor signaling. Brain Res. Mol. Brain Res. 136, 23 28.
36. Kolodziej S. J., Kluppelberg H. U., Nolasco N., Ehses W., Strickland D. K. Stoops J. K. (1998) Three-dimensional structure of the human plasmin alpha2-macroglobulin complex. J. Struct. Biol. 123, 124 133.
37. LaMarre J., Wollenberg G. K., Gonias S. L. Hayes M. A. (1991a) Reaction of alpha 2-macroglobulin with plasmin increases binding of transforming growth factors-beta 1 and beta 2. Biochim. Biophys. Acta 1091, 197 204.
38. LaMarre J., Hayes M. A., Wollenberg G. K., Hussaini I., Hall S. W. Gonias S. L. (1991b) An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice. J. Clin. Invest. 87, 39 44.
39. Lee J. C., Laydon J. T., McDonnell P. C. et al. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739 746.
40. van Leuven F., Torrekens S., Overbergh L., Lorent K., de Strooper B. van den Berghe H. (1992) The primary sequence and the subunit structure of mouse alpha-2-macroglobulin, deduced from protein sequencing of the isolated subunits and from molecular cloning of the cDNA. Eur. J. Biochem. 210, 319 327.
41. Liefner M., Siebert H., Sachse T., Michel U., Kollias G. Bruck W. (2000) The role of TNF-alpha during Wallerian degeneration. J. Neuroimmunol. 108, 147 152.
42. Livak K. J. Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402 408.
43. Lutz C., Nimpf J., Jenny M., Boecklinger K., Enzinger C., Utermann G., Baier-Bitterlich G. Baier G. (2002) Evidence of functional modulation of the MEKK/JNK/cJun signaling cascade by the low density lipoprotein receptor-related protein (LRP). J. Biol. Chem. 277, 43143 43151.
44. Marshall L. B., Figler N. L. Gonias S. L. (1992) Identification of alpha 2-macroglobulin conformational intermediates by electron microscopy and image analysis. Comparison of alpha 2-macroglobulin-thrombin and alpha 2-macroglobulin reacted with cis- dichlorodiammineplatinum(II) and trypsin. J. Biol. Chem. 267, 6347 6352.
45. May P., Reddy Y. K. Herz J. (2002) Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277, 18736 18743.
46. Menge T., Jander S. Stoll G. (2001) Induction of the proinflammatory cytokine interleukin-18 by axonal injury. J. Neurosci. Res. 65, 332 339.
47. Mettenburg J. M., Webb D. J. Gonias S. L. (2002) Distinct binding sites in the structure of alpha 2-macroglobulin mediate the interaction with beta-amyloid peptide and growth factors. J. Biol. Chem. 277, 13338 13345.
48. Misra U. K., Gonzalez-Gronow M., Gawdi G., Hart J. P., Johnson C. E. Pizzo S. V. (2002) The role of Grp 78 in alpha 2-macroglobulin-induced signal transduction. Evidence from RNA interference that the low density lipoprotein receptor-related protein is associated with, but not necessary for, GRP 78-mediated signal transduction. J. Biol. Chem. 277, 42082 42087.
49. Misra U. K., Gonzalez-Gronow M., Gawdi G., Wang F. Pizzo S. V. (2004) A novel receptor function for the heat shock protein Grp78: silencing of Grp78 gene expression attenuates alpha2M*-induced signalling. Cell. Signal. 16, 929 938.
50. Mueller M., Leonhard C., Wacker K., Ringelstein E. B., Okabe M., Hickey W. F. Kiefer R. (2003) Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages. Lab. Invest. 83, 175 185.
51. Murata Y., Onda A., Rydevik B., Takahashi K. Olmarker K. (2004) Selective inhibition of tumor necrosis factor-alpha prevents nucleus pulposus-induced histologic changes in the dorsal root ganglion. Spine 29, 2477 2484.
52. Myers R. R. (1995) 1994 ASRA Lecture. The pathogenesis of neuropathic pain. Reg. Anesth. 20, 173 184.
53. Myers R. R., Sekiguchi Y., Kikuchi S., Scott B., Medicherla S., Protter A. Campana W. M. (2003) Inhibition of p38 MAP kinase activity enhances axonal regeneration. Exp. Neurol. 184, 606 614.
54. Myers R. R., Campana W. M. Shubayev V. I. (2006) The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov. Today 11, 8 20.
55. Nelles L. P., Hall P. K. Roberts R. C. (1980) Human alpha-2- macroglobulin. Studies on the electrophoretic heterogeneity. Biochim. Biophys. Acta 623, 46 56.
56. Newton C. S., Loukinova E., Mikhailenko I., Ranganathan S., Gao Y., Haudenschild C. Strickland D. K. (2005) Platelet-derived growth factor receptor-beta (PDGFR-beta) activation promotes its association with the low density lipoprotein receptor-related protein (LRP). Evidence for co-receptor function. J. Biol. Chem. 280, 27872 27878.
57. Orr A. W., Elzie C. A., Kucik D. F. Murphy-Ullrich J. E. (2003) Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. J. Cell Sci. 116, 2917 2927.
58. Overbergh L., Torrekens S., Van Leuven F. Van den Berghe H. (1991) Molecular characterization of the murinoglobulins. J. Biol. Chem. 266, 16903 16910.
59. Overbergh L., Lorent K., Hilliker C. Van Leuven F. (1994a) Characterization of the genes coding for the murinoglobulins and expression in vivo. Ann. NY Acad. Sci. 737, 496 497.
60. Overbergh L., Hilliker C., Lorent K., Van Leuven F. Van den Berghe H. (1994b) Identification of four genes coding for isoforms of murinoglobulin, the monomeric mouse alpha 2-macroglobulin: characterization of the exons coding for the bait region. Genomics 22, 530 539.
61. Paul W. E. (1991) Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77, 1859 1870.
62. Pfaffl M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
63. Pizzo S. V. Gonias S. L. (1984) Receptor-mediated protease regulation, Vol. 1, pp 178 221. Academic Press, Orlando, FL.
64. Qazi U., Gettins P. G. W. Stoops J. K. (1998) On the structural changes of native human alpha2-macroglobulin upon proteinase entrapment. J. Biol. Chem. 273, 8987 8993.
65. Qazi U., Gettins P. G. W., Strickland D. K. Stoops J. K. (1999) Structural details of proteinase entrapment by human alpha2-macroglobulin emerge from the three-dimensional reconstructions of Fab labeled native, half-transformed and transformed molecules. J. Biol. Chem. 274, 8137 8142.
66. Qiu Z., Strickland D. K., Hyman B. T. Rebeck G. W. (2002) α-2-Macroglobulin exposure reduces calcium responses to N-methyl-D-aspartate via low density lipoprotein receptor-related protein in cultured hippocampal neurons. J. Biol. Chem. 277, 14458 14466.
67. Reichert F., Levitzky R. Rotshenker S. (1996) Interleukin 6 in intact and injured mouse peripheral nerves. Eur. J. Neurosci. 8, 530 535.
68. Roche P. A. Pizzo S. V. (1988) Analysis of thiolester bond cleavage-dependent conformational changes in binary alpha2-macroglobulin complexes. Arch. Biochem. Biophys. 267, 285 293.
69. Ruff E. Rizzino A. (1986) Preparation and binding of radioactively labeled porcine transforming growth factor type beta. Biochem. Biophys. Res. Commun. 138, 714 719.
70. Samonte I. E., Sato A., Mayer W. E., Shintani S. Klein J. (2002) Linkage relationships of genes coding for alpha2-macroglobulin, C3 and C4 in the zebrafish: implications for the evolution of the complement and Mhc systems. Scand. J. Immunol. 56, 344 352.
71. Schafers M., Geis C., Svensson C. I., Luo Z. D. Sommer C. (2003) Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur. J. Neurosci. 17, 791 804.
72. Scheidt P. Friede R. L. (1987) Myelin phagocytosis in Wallerian degeneration. Properties of millipore diffusion chambers and immunohistochemical identification of cell populations. Acta Neuropathol. (Berl.) 75, 77 84.
73. Selzer Z., Dubner R. Shir Y. (1990) A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43, 205 218.
74. Shamash S., Reichert F. Rotshenker S. (2002) The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 22, 3052 3060.
75. Shubayev V. I. Myers R. R. (2000) Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res. 855, 83 89.
76. Shubayev V. I., Angert M., Dolkas J., Campana W. M., Palenscar K. Myers R. R. (2006) TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve. Mol. Cell. Neurosci. 31, 407 415.
77. Sommer C., Lalonde A., Heckman H. M., Rodriguez M. Myers R. R. (1995) Quantitative neuropathology of a focal nerve injury causing hyperalgesia. J. Neuropathol. Exp. Neurol. 54, 635 643.
78. Sorkin L. S., Xiao W. H., Wagner R. Myers R. R. (1997) Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 81, 255 262.
79. Sottrup-Jensen L. (1987) In the plasma proteins, Vol. 5, pp 192 291. Academic Press, Inc., Orlando.
80. Steiner J. P., Bhattacharya P. Strickland D. K. (1985) Thrombin-induced conformational changes of human alpha2-macroglobulin: evidence for two functional domains. Biochemistry 24, 2993 3001.
81. Stoll G., Jander S. Myers R. R. (2002) Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J. Peripher. Nerv. Syst. 7, 13 27.
82. Taskinen H. S., Olsson T., Bucht A., Khademi M., Svelander L. Roytta M. (2000) Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA. J. Neuroimmunol. 102, 17 25.
83. Uceyler N., Valenza R., Stock M., Schedel R., Sprotte G. Sommer C. (2006) Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum. 54, 2656 2664.
84. Wagner R. Myers R. R. (1996a) Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport 7, 2897 2901.
85. Wagner R. Myers R. R. (1996b) Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 73, 625 629.
86. Wagner R., Janjigian M. Myers R. R. (1998) Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression. Pain 74, 35 42.
87. Webb D. J. Gonias S. L. (1997) Chemical modification of alpha2-macroglobulin to generate derivatives that bind transforming growth factor-beta with increased affinity. FEBS Lett. 410, 249 253.
88. Webb D. J. Gonias S. L. (1998) A modified human alpha 2-macroglobulin derivative that binds tumor necrosis factor-alpha and interleukin-1 beta with high affinity in vitro and reverses lipopolysaccharide toxicity in vivo in mice. Lab. Invest. 78, 939 948.
89. Webb D. J., Nguyen D. H. Gonias S. L. (2000a) Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion. J. Cell Sci. 113 (Pt. 1 123 134.
90. Webb D. J., Roadcap D. W., Dhalephalkar A. Gonias S. L. (2000b) A 16-amino acid peptide from human alpha2-macroglobulin binds transforming growth factor-beta and platelet-derived growth factor-BB. Protein Sci. 9, 1986 1992.